Immunohistochemical analysis of expression and allelotype of mismatch repair genes (hMLH1 and hMSH2) in bladder cancer.
dc.contributor.author | Kassem, Heba S | |
dc.contributor.author | Varley, Jennifer | |
dc.contributor.author | Hamam, S M | |
dc.contributor.author | Margison, Geoffrey P | |
dc.date.accessioned | 2009-11-06T16:49:00Z | |
dc.date.available | 2009-11-06T16:49:00Z | |
dc.date.issued | 2001-02-02 | |
dc.identifier.citation | Immunohistochemical analysis of expression and allelotype of mismatch repair genes (hMLH1 and hMSH2) in bladder cancer. 2001, 84 (3):321-8 Br. J. Cancer | en |
dc.identifier.issn | 0007-0920 | |
dc.identifier.pmid | 11161395 | |
dc.identifier.doi | 10.1054/bjoc.2000.1595 | |
dc.identifier.uri | http://hdl.handle.net/10541/85606 | |
dc.description.abstract | Mutation of human homologues of DNA mismatch repair (MMR) genes in tumours has been shown to be associated with the phenomenon of microsatellite instability (MSI). Several studies have reported the occurrence of MSI in bladder cancer, but evidence of involvement of MMR genes in the pathogenesis of this cancer is still unclear. We therefore utilized quantitative immunohistochemical (IHC) image analysis and PCR-based allelotype analysis to determine hMLH1 and hMSH2 genes alteration in a cohort of Egyptian bladder cancer samples. IHC analysis of 24 TCC and 12 SCC revealed marked- intra and intertumour heterogeneity in the levels of expression of the two MMR proteins. One TCC lost MLH1 expression and one lost MSH2, (1/24, 4%), and one SCC lost MSH2 (1/12, 8%). A large proportion of analysed tumours revealed a percentage positivity of less than 50% for MLH1 and MSH2 expression (44% and 69%, respectively). Complete loss of heterozygosity in three dinucleotide repeats lying within, or in close proximity to, hMLH1 and hMSH2 was rare (2/57, (4%) for MLH1; and 1/55, (2%) for MSH2), however allelic imbalance was detected in 11/57 (hMLH1) and 10/55 (hMSH2) at any of the informative microsatellite loci. These alterations in structure and expression of DNA MMR genes suggest their possible involvement in the tumorigenesis and/or progression of bladder cancer. | |
dc.language.iso | en | en |
dc.subject | Cancer DNA | en |
dc.subject | Cancerous Gene Expression Regulation | en |
dc.subject | Cancer Proteins | en |
dc.subject | Urinary Bladder Cancer | en |
dc.subject.mesh | Adaptor Proteins, Signal Transducing | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Alleles | |
dc.subject.mesh | Allelic Imbalance | |
dc.subject.mesh | Carrier Proteins | |
dc.subject.mesh | DNA, Neoplasm | |
dc.subject.mesh | DNA-Binding Proteins | |
dc.subject.mesh | Female | |
dc.subject.mesh | Gene Expression Regulation, Neoplastic | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Immunohistochemistry | |
dc.subject.mesh | Loss of Heterozygosity | |
dc.subject.mesh | Male | |
dc.subject.mesh | Microsatellite Repeats | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | MutS Homolog 2 Protein | |
dc.subject.mesh | Neoplasm Proteins | |
dc.subject.mesh | Nuclear Proteins | |
dc.subject.mesh | Polymerase Chain Reaction | |
dc.subject.mesh | Proto-Oncogene Proteins | |
dc.subject.mesh | Urinary Bladder Neoplasms | |
dc.title | Immunohistochemical analysis of expression and allelotype of mismatch repair genes (hMLH1 and hMSH2) in bladder cancer. | en |
dc.type | Article | en |
dc.contributor.department | CRC Carcinogenesis Group, UK. | en |
dc.identifier.journal | British Journal of Cancer | en |
html.description.abstract | Mutation of human homologues of DNA mismatch repair (MMR) genes in tumours has been shown to be associated with the phenomenon of microsatellite instability (MSI). Several studies have reported the occurrence of MSI in bladder cancer, but evidence of involvement of MMR genes in the pathogenesis of this cancer is still unclear. We therefore utilized quantitative immunohistochemical (IHC) image analysis and PCR-based allelotype analysis to determine hMLH1 and hMSH2 genes alteration in a cohort of Egyptian bladder cancer samples. IHC analysis of 24 TCC and 12 SCC revealed marked- intra and intertumour heterogeneity in the levels of expression of the two MMR proteins. One TCC lost MLH1 expression and one lost MSH2, (1/24, 4%), and one SCC lost MSH2 (1/12, 8%). A large proportion of analysed tumours revealed a percentage positivity of less than 50% for MLH1 and MSH2 expression (44% and 69%, respectively). Complete loss of heterozygosity in three dinucleotide repeats lying within, or in close proximity to, hMLH1 and hMSH2 was rare (2/57, (4%) for MLH1; and 1/55, (2%) for MSH2), however allelic imbalance was detected in 11/57 (hMLH1) and 10/55 (hMSH2) at any of the informative microsatellite loci. These alterations in structure and expression of DNA MMR genes suggest their possible involvement in the tumorigenesis and/or progression of bladder cancer. |